| Issue Date | Title | Author(s) |
| 2015-03 | Adaptation, face and content validation of a palliative care needs assessment tool for people with interstitial lung disease. | Reigada, C; Bajwah, S; Ross, J; Boland, J; Wells, A; Yorke, J; Grande, G; Hart, S; Currow, D; Papadopoulos, T; Macleod, U; Johnson, M |
| 2016-05-01 | The Adaptation, Face, and Content Validation of a Needs Assessment Tool: Progressive Disease for People with Interstitial Lung Disease | Boland, JW; Reigada, C; Yorke, J; Hart, SP; Bajwah, S; Ross, J; Wells, A; Papadopoulos, A; Currow, DC; Grande, G; Macleod, U; Johnson, MJ |
| 2023-08 | European Respiratory Society clinical practice guideline: palliative care for people with COPD or interstitial lung disease. | Janssen, DJA; Bajwah, S; Boon, MH; Coleman, C; Currow, DC; Devillers, A; Vandendungen, C; Ekström, M; Flewett, R; Greenley, S; Guldin, M-B; Jácome, C; Johnson, MJ; Kurita, GP; Maddocks, M; Marques, A; Pinnock, H; Simon, ST; Tonia, T; Marsaa, K |
| 2017-11-01 | Implementation of the Needs Assessment Tool for patients with interstitial lung disease (NAT:ILD): Facilitators and barriers | Reigada, C; Papadopoulos, A; Boland, JW; Yorke, J; Ross, J; Currow, DC; Hart, S; Bajwah, S; Grande, G; Wells, A; Johnson, MJ |
| 2021-01 | Indications and patterns of use of benzodiazepines and opioids in severe interstitial lung disease: a population-based longitudinal study. | Genberg, J; Davies, JM; Ahmadi, Z; Currow, D; Johnson, MJ; Tanash, H; Bajwah, S; Ekström, M |
| 2020-04-08 | Managing the supportive care needs of those affected by COVID-19. | Bajwah, S; Wilcock, A; Towers, R; Costantini, M; Bausewein, C; Simon, ST; Bendstrup, E; Prentice, W; Johnson, MJ; Currow, DC; Kreuter, M; Wells, AU; Birring, SS; Edmonds, P; Higginson, IJ |
| 2023-07 | Modified-release morphine or placebo for chronic breathlessness: the MABEL trial protocol. | Date, K; Williams, B; Cohen, J; Chaudhuri, N; Bajwah, S; Pearson, M; Higginson, I; Norrie, J; Keerie, C; Tuck, S; Hall, P; Currow, D; Fallon, M; Johnson, M |
| 2018-01-01 | One evidence base; three stories: do opioids relieve chronic breathlessness? | Ekström, M; Bajwah, S; Bland, JM; Currow, DC; Hussain, J; Johnson, MJ |
| 2021-09 | Professionals', patients' and families' views on the use of opioids for chronic breathlessness: A systematic review using the framework method and pillar process. | Reedy, F; Pearson, M; Greenley, S; Clark, J; Currow, DC; Bajwah, S; Fallon, M; Johnson, MJ |
| 2018-09-01 | Psychometric validation of the needs assessment tool: Progressive disease in interstitial lung disease | Johnson, MJ; Jamali, A; Ross, J; Fairhurst, C; Boland, J; Reigada, C; Hart, SP; Grande, G; Currow, DC; Wells, AU; Bajwah, S; Papadopoulos, T; Bland, JM; Yorke, J |
| 2020-02-01 | Randomised, double-blind, multicentre, mixed-methods, dose-escalation feasibility trial of mirtazapine for better treatment of severe breathlessness in advanced lung disease (BETTER-B feasibility) | Higginson, IJ; Wilcock, A; Johnson, MJ; Bajwah, S; Lovell, N; Yi, D; Hart, SP; Crosby, V; Poad, H; Currow, D; Best, E; Brown, S |
| 2018-12-01 | Safety of benzodiazepines and opioids in interstitial lung disease: A national prospective study | Bajwah, S; Davies, JM; Tanash, H; Currow, DC; Oluyase, AO; Ekström, M |
